Modeling of longitudinal immune profiles reveals distinct immunogenic signatures following five COVID-19 vaccinations among people living with HIV.
Where this comes from
- Record sourced from PubMed, PMID 42028410.
- Also identified by DOI 10.1016/j.patter.2025.101474 and PMC identifier 13100683.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
The immune response to vaccination is highly heterogeneous and arises from a dynamic interplay of immune components. Harnessing machine learning (ML) to learn immune interdependencies offers the potential not only to decode immune signatures linked to a specified comorbidity but also to reveal individualized patterns laying the groundwork for precision-guided vaccination and targeted clinical follow-up. We employ a random forest (RF) approach to classify informative differences in immunogenicity between older people living with HIV (PLWH) on antiretroviral therapy (ART) and an age-matched control group who received up to five SARS-CoV-2 vaccinations. RFs identify evidence for T helper 1 (Th1) imprinting and reveal novel distinguishing immune features, such as saliva-based antibody screening, as promising diagnostic tools (whereas serum IgG is not). Our modeling approach reveals a subset of PLWH whose immune signatures are indistinguishable from the HIV- control group, which we interpret as near-complete immune restoration from a longitudinal vaccine-elicited immunogenic perspective. To expand the utility of our findings, we generate privacy-preserving synthetic "virtual patients" that accurately approximate the original longitudinal immunologic data and show, via train-on-synthetic/test-on-real evaluation, that RF classifiers trained solely on virtual patients generalize to held-out real patients. Our results highlight the effectiveness in utilizing informative immune feature interdependencies for classification tasks and suggest broad impacts of ML applications for personalized vaccination strategies among high-risk populations.